Extrusion and spheronization in the development of oral controlled- release dosage forms

Pharmaceutical Science and Technology Today

Volumn 2, Issue 4, 1999, Pages 160-170

  Gandhi, Rajesh ^a   Kaul, Chaman Lal ^a   Panchagnula, Ramesh ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG RELEASE; COST EFFECTIVENESS ANALYSIS; DRUG FORMULATION; REVIEW; SPHERONIZATION;

EID: 0033119993     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00136-4     Document Type: Review

References (81)

1. 1 Berner, B. and Dinh, S. (1992) in Treatise on Controlled Drug Delivery (Kydonieus, A., ed.), pp. 1-29, Marcel Dekker
2. 2 Lordi, N.G. (1986) in The Theory and Practice of Industrial Pharmacy (Lachman, H.A. and Kang, J.L., eds), pp 430-456, Lea and Febiger, Philadelphia, PA, USA
3. 3 Hussay, U.K. et al. (1991) J. Clin. Pharmacol. 31, 361-364
4. 4 Katznendler, I. et al. (1997) J. Pharm. Sci. 86, 110-115
5. 5 Nellore, R.V. et al. (1998) J. Control. Release 50, 247-256
6. 6 Gupta, P. et al. (1996) Eur. J. Pharm. Biopharm. 42, 74-81
7. 7 Vandelli, M.A., Leo, E. and Forni, F. (1995) Eur. J. Pharm. Biopharm. 41, 262-265
8. 8 Parikh, B.M. (1990) Alternatives for Processing Spherical Granules, paper presented at Interphex USA, 10 May, New York, NY, USA
9. 9 Vervaet, C., Baert, L. and Remon, J.P. (1995) Int. J. Pharm. 116, 131-146
10. 10 Eskilson, C. (1985) Manuf. Chem. 56(3), 33-39
11. 11 Bechgaard, H. and Hegermann-Nielsen, G. (1978) Drug Dev. Ind. Pharm. 4, 53-67
12. 12 Ghebre-Sellassie, I. (1989) in Pharmaceutical Pelletization Technology (Ghebre-Sellassie, I., ed.), pp. 1-13, Marcel Dekker
13. 13 Govender, T. and Dangor, C.M. (1997) J. Microencapsulation 14, 445-455
14. 14 Reynolds, A.D. (1970) Manuf. Chem. Aerosol News 41, 40-43
15. 15 Bechard, S.R. and Leroux, J.C. (1992) Drug Dev. Ind. Pharm. 18, 1927-1944
16. 16 Canefe, K. and Comoglu. T. (1997) J. Control. Release 48, 343
17. 17 Mathir, J.M. et al. (1997) J. Microencapulation 14, 743-751
18. 18 Robinson, R.L. and Hollenbeck, R.G. (1991) Pharm. Technol. 15(7), 48-56
19. 19 Jaiswal, S.B. et al. (1995) Drug Dev. Ind. Pharm. 21, 2109-2120
20. 20 Chambliss, W.G. (1989) in Pharmaceutical Pelletization Technology (Ghebre-Sellassie, I., ed.), pp. 15-38, Marcel Dekker
21. 21 Zhang, G. et al. (1991) Drug Dev. Ind. Pharm. 17, 817-830
22. 22 Nakahara, N (1964) US Patent 3 227-520
23. 23 Conine, J.W. and Hadley, H.R. (1970) Drug Cosmet. Ind. 106, 38-41
24. 24 O'Connor, R.E., Holinej, J. and Schwartz, J.B. (1984) Am. J. Pharm. 156, 80-87
25. 25 O'Connor, R.E. and Schwartz, J.B. (1985) Drug Dev. Ind. Pharm. 11, 1837-1857
26. 26 Ku, C.C. et al. (1993) Drug Dev. Ind. Pharm. 19, 1505-1519
27. 27 Hellen, L. and Yliruusi J. (1993) Int. J. Pharm. 96, 217-223
28. 28 Baert, L. and Remon, J.P. (1993) Int. J. Pharm. 95, 135-141
29. 29 Murphy, M.P. and Hollenbeck, R.G. (1998) Pharm. Technol. 22(4), 94-102
30. 30 Hellen, L. et al. (1992) Pharm. Tech. Int. Biophys 4, 50-60
31. 31 Hicks, D.C. and Freese, H.L. (1989) in Pharmaceutical Pelletization Technology (Ghebre-Sellassie, I., ed.), pp. 71-100, Marcel Dekker
32. 32 Fielden, K.E., Newton, J.M. and Rowe, R.C. (1992) Int. J. Pharm. 81, 222-233
33. 33 Goskonda, S.R. and Upadrashta, S.M. (1993) Drug Dev. Ind. Pharm. 19, 915-927
34. 34 Bataille, B. et al. (1993) Drug Dev. Ind. Pharm. 19, 653-671
35. 35 Dyer, A.M., Khan, K.A. and Aulton, M.E. (1994) Drug Dev. Ind. Pharm. 20, 3045-3068
36. 36 Rowe, R.C. (1985) Pharm. Int. 6, 119-123
37. 37 Ostuka, A.M., Gao, J. and Matsuda, Y. (1994) Drug Dev. Ind. Pharm. 20, 2977-2992
38. 38 Fielden, K.E., Newton, J.M. and Rowe, R.C. (1993) Int. J. Pharm. 97, 79-92
39. 39 Gazzaniga, A. et al. (1998) Drug Dev. Ind. Pharm. 24, 869-873
40. 40 Newton, J.M., Chow, A.K. and Jeewa, K.B. (1992) Pharm. Tech. Int. Biophys. 4, 52-58
41. 41 Law, M.F.L., Deasy, D.B. and Mclaughlin, J.P. (1997) J. Microencapsulation 14, 713-723
42. 42 Sonagllo, D. et al. (1995) Drug Dev. Ind. Pharm. 21 (5), 533-547
43. 43 Herman, J., Remon, J.P. and Lefebure, R. (1988) J. Pharm. Pharmacol. 40, 157-160
44. 44 Millili, G.P and Schwartz, J.B. (1990) Drug Dev. Ind. Pharm. 16, 1411-1426
45. 45 Baert, L. et al. (1992) Int. J. Pharm. 86, 187-192
46. 46 Baert, L. et al. (1993) Int. J. Pharm. 99, 7-12
47. 47 Hellen, L. et al. (1993) Pharm. Tech. Int. Biophys. 5, 44-53
48. 48 Harrison, P.J., Newton, J.M. and Rowe, R.C. (1985) J. Pharm. Pharmacol. 37, 81-83
49. 49 Bianchini, R. et al. (1992) Drug Dev. Ind. Pharm. 18, 1485-1503
50. 50 Fielden, K.E. et al. (1988) J. Pharm. Pharmacol. 40, 674-678
51. 51 Dietrich, R. and Brausse, R. (1988) Pharm. Ind. 50, 1179-1186
52. 52 Kleinebudde, P. and Linder, H. (1993) Int. J. Pharm. 94, 49-58
53. 53 Newton, J.M., Chapman, S.R. and Rowe, R.C. (1995) Int. J. Pharm. 120, 101-109
54. 54 Barrau, J.P., Bataille, B. and Jacob, M. (1993) Pharm. Technol. Int. 66, 68-70
55. 55 Hellen, L. et al. (1993) Int. J. Pharm. 96, 197-204
56. 56 Bataille, B. et al. (1993) Drug Dev. Ind. Pharm. 19(6), 653-671
57. 57 Malinowski, H.J. and Smith, W.E. (1975) J. Pharm. Sci. 64, 1688-1692
58. 58 Betageri, G.V., Kurumaddali, K.R. and Ravis, W.R. (1995) Drug Dev. Ind. Pharm. 21, 265-275
59. 59 The United States Pharmacopoeia/National Formulary (1995) (Asian edition), p. 2313, The United States Pharmacopoeial Convention, Inc., Rockville, MD, USA
60. 60 Werner, D. (1996) Pharm. Manuf. Rev. 8, 26-29
61. 61 Shah, R.D. et al. (1995) Pharm. Res. 12, 496-507
62. 62 Chatlapalli, R. and Rohera, B.D. (1998) Int. J. Pharm. 161, 179-193
63. 63 Porter, S.C. (1995) in Remington - The Science and Practice of Pharmacy, pp. 1651-1660, Mack Publishing Company, PA, USA
64. 64 Tuen, K.H., Deshmukh, A.A. and Newton, J.M. (1993) Drug Dev. Ind. Pharm. 19, 855-875
65. 65 Venkatesh, H. and Sanghavi, N.M. (1994) Drug Dev. Ind. Pharm. 20, 111-118
66. 66 Schultz, S.P. and Kleinebudde, P. (1997) J. Control. Release 47, 181-184
67. 67 Dyer, A.M., Khan, K.A. and Aulton, M.E. (1995) Drug Dev. Ind. Pharm. 21, 1841-1858
68. 68 Zhou, F., Vervaet, C. and Remon, J.P. (1996) Int. J. Pharm. 133, 155-160
69. 69 Veiga, F., Salsa, T. and Pina, M.E. (1998) Drug Dev. Ind. Pharm. 24, 1-9
70. 70 Salsa, T., Veiga, F. and Pina, M.E. (1997) Drug Dev. Ind. Pharm. 23, 929-938
71. 71 Hui, H.W. and Robinsons, J.R. (1987) in Controlled Drug Delivery Fundamentals and Applications (Robinson, J.R. and Lee. V.H.L., eds), pp. 374-420, Marcel Dekker
72. 72 Ghali, E.S., Klinger, G.H. and Schwartz, J.B. (1989) Drug Dev. Ind. Pharm. 15, 1455-1473
73. 73 Briquet, F. et al. (1986) STP Pharma. 2, 986-994
74. 74 Ghali, E.S., Klinger, G.H. and Schwartz, J.B. (1989) Drug Dev. Ind. Pharm. 15, 1311-1328
75. 75 Goskonda, S.R., Hileman, G.A. and Upadrashta, S.M. (1994) Int. J. Pharm. 111, 89-97
76. 76 Goskonda, S.R., Hileman, G.A. and Upadrashta, S.M. (1994) Drug Dev. Ind. Pharm. 20, 279-292
77. 77 Tapia, C., Buckton, G. and Newton, J.M. (1993) Int. J. Pharm. 92, 211-218
78. 78 Peh, K.K. and Yuen, K.H. (1995) Drug Dev. Ind. Pharm. 21, 1545-1555
79. 79 Blanque, D. et al. (1995) Int. J. Pharm. 119, 203-211
80. 80 Neau, S.H., Chow, M.Y. and Durrani, M.J. (1996) Int. J. Pharm. 131, 47-55
81. 81 Sood, A. and Panchagnula, R. (1998) J. Pharm. Pharmacol. 50, 181